Relapsing course of immunoglobulin g4-related pachymeningitis

Neurology

Volumn 79, Issue 6, 2012, Pages 604-605

  Shapiro, Kevin A ^a   Bové, Riley M ^a   Volpicelli, Elgida R ^b   Mallery, Robert M ^a   Stone, John H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB;

ADULT; ARTICLE; BRAIN DISEASE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CRANIAL NEUROPATHY; DYSPHAGIA; FACE PAIN; FEMALE; HEADACHE; HEARING LOSS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN G4 RELATED PACHYMENINGITIS; IMMUNOPATHOLOGY; LUMBAR PUNCTURE; MASTOIDITIS; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOPHOBIA; PLASMA CELL; PLEOCYTOSIS; PRIORITY JOURNAL; RELAPSE; SCLEROSIS; SLURRED SPEECH; SYMPTOM; TREATMENT RESPONSE; VOCAL CORD PARALYSIS;

EID: 84866055866     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31826356fc     Document Type: Article

References (7)

1. Khosroshahi A, Stone JH. A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol 2011;23: 57-66.
2. Choi S-H, Lee SH, Khang SK, Sang RJ. IgG4-related sclerosing pachymeningitis causing spinal cord compression. Neurology 2010;75:1388 -1389.
3. Chan S-K, Cheuk W, Chan K-T, Chan JKC. IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease. Am J Surg Pathol 2009;33: 1249-1252.
4. Kosakai A, Ito D, Yamada S, Ideta S, Ota Y, Suzuki N. A case of definite IgG4-related pachymeningitis. Neurology 2010;75:1390 -1392.
5. Lindstrom KM, Cousar JB, Lopes MBS. IgG4-related meningeal disease: clinico-pathologic features and proposal for diagnostic criteria. Acta Neuropathol 2010;120:765-776.
6. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009; 58:1504 -1507.
7. Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 2010;62:1755-1762.